This study is looking at how a special type of care, called intensive multi-disciplinary care, affects people with newly diagnosed brain metastases (cancer that has spread to the brain). It compares this special care to the usual care you would receive. The study wants to see how these different care approaches impact your symptoms and how well you understand your condition. You can join if you are at least 18 years old, have newly diagnosed brain metastases from a solid tumor, and can accurately share information about your health. The study aims to enroll 40 people, but its current status is unclear.

Study design

This study is comparing two groups of patients: one receiving standard care and another receiving intensive multi-disciplinary care. It plans to include 40 participants.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

Your patient-reported outcomes will be measured between 6 and 12 months after starting the study.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.